These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 25891740)
1. Treatment-resistant recurrent membranoproliferative glomerulonephritis in renal allograft responding to rituximab: case report. Farooqui M; Alsaad K; Aloudah N; Alhamdan H Transplant Proc; 2015 Apr; 47(3):823-6. PubMed ID: 25891740 [TBL] [Abstract][Full Text] [Related]
2. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft. Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798 [TBL] [Abstract][Full Text] [Related]
3. Recurrent membranoproliferative glomerulonephritis after second renal graft treated with plasmapheresis and rituximab. Pérez-Sáez MJ; Toledo K; Navarro MD; Lopez-Andreu M; Redondo MD; Ortega R; Pérez-Seoane C; Agüera ML; Rodríguez-Benot A; Aljama P Transplant Proc; 2011 Dec; 43(10):4005-9. PubMed ID: 22172889 [TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent, post-kidney transplant membranoproliferative glomerulonephritis with plasmapheresis and rituximab: A case report and literature review . Yango AF; Fischbach BV; Ruiz R; Mudrovich S; Klintmalm G Clin Nephrol; 2019 Jan; 91(1):52-58. PubMed ID: 30431428 [TBL] [Abstract][Full Text] [Related]
5. Recurrent Proliferative Glomerulonephritis With Monoclonal IgG Deposits After a Renal Transplant Which Was Insensitive to Pulse Therapy Remitted by Double Filtration Plasmapheresis. Wu D; Chen JS; Cheng DR; Chen H; Li X; Ji SM; Xie KN; Ni XF; Liu ZH; Wen JQ Exp Clin Transplant; 2015 Oct; 13(5):467-70. PubMed ID: 25275829 [TBL] [Abstract][Full Text] [Related]
6. Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection. Mak SK; Lo KY; Lo MW; Chan SF; Lo KC; Wong YY; Tong GM; Wong PN; Ma ES; Wong AK Hong Kong Med J; 2009 Jun; 15(3):201-8. PubMed ID: 19494376 [TBL] [Abstract][Full Text] [Related]
7. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft. Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743 [TBL] [Abstract][Full Text] [Related]
8. Plasmapheresis maintained renal function in an allograft with recurrent membranoproliferative glomerulonephritis type I. Muczynski KA Am J Nephrol; 1995; 15(5):446-9. PubMed ID: 7503148 [TBL] [Abstract][Full Text] [Related]
9. De novo proliferative glomerulonephritis with monoclonal IgG deposits of the IgG1κ subtype in a kidney allograft. Tsuji T; Miura M; Yanai M; Itami H; Ishii Y; Akimoto M; Fukasawa Y Nephrology (Carlton); 2016 Jul; 21 Suppl 1():44-7. PubMed ID: 26976360 [TBL] [Abstract][Full Text] [Related]
10. Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies. Rudnicki M Biomed Res Int; 2017; 2017():2180508. PubMed ID: 28573137 [TBL] [Abstract][Full Text] [Related]
12. Recurrent type I membranoproliferative glomerulonephritis after renal transplantation and protective role of cyclosporine in acute crescentic transformation. Ahsan N; Manning EC; Dabbs DJ; Gifford RR; Yang HC Clin Transplant; 1997 Feb; 11(1):9-14. PubMed ID: 9067687 [TBL] [Abstract][Full Text] [Related]
13. Recurrence of membranoproliferative glomerulonephritis post transplant - Is this mere recurrence of pattern or recurrence of disease? Lingaraj U; Patil SR; Aralapuram K; Mallappa SS; Gurusiddaiah SC; Vankalakunti M Saudi J Kidney Dis Transpl; 2019; 30(3):719-722. PubMed ID: 31249240 [TBL] [Abstract][Full Text] [Related]
14. Rituximab treatment for immune-complex-mediated membranoproliferative glomerulonephritis. Lu Q; Zuo L; Dong B; Yan Y; Yang B Immunotherapy; 2018 Sep; 10(12):1027-1031. PubMed ID: 30185139 [TBL] [Abstract][Full Text] [Related]
15. A 65-year-old man with early renal allograft dysfunction. Hill PA; Crikis S; Goodman DG Am J Kidney Dis; 2003 Jul; 42(1):207-11. PubMed ID: 12830474 [No Abstract] [Full Text] [Related]
16. Severe recurrence of type I membranoproliferative glomerulonephritis after transplantation: remission on steroids and cyclophosphamide. Cahen R; Trolliet P; Dijoud F; Megri K; François B Transplant Proc; 1995 Apr; 27(2):1746-7. PubMed ID: 7725484 [No Abstract] [Full Text] [Related]
17. Recurrent type I membranoproliferative glomerulonephritis in a renal allograft: successful treatment with plasmapheresis. Saxena R; Frankel WL; Sedmak DD; Falkenhain ME; Cosio FG Am J Kidney Dis; 2000 Apr; 35(4):749-52. PubMed ID: 10739799 [TBL] [Abstract][Full Text] [Related]
18. Rituximab therapy for Type I membranoproliferative glomerulonephritis. Dillon JJ; Hladunewich M; Haley WE; Reich HN; Cattran DC; Fervenza FC Clin Nephrol; 2012 Apr; 77(4):290-5. PubMed ID: 22445472 [TBL] [Abstract][Full Text] [Related]
19. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases. Masutani K; Katafuchi R; Ikeda H; Yamamoto H; Motoyama K; Sugitani A; Kanai H; Kumagai H; Hirakata H; Tanaka M; Iida M Clin Transplant; 2005; 19 Suppl 14():59-64. PubMed ID: 15955171 [TBL] [Abstract][Full Text] [Related]
20. Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation. Marques ID; Ramalho J; David DR; Nahas WC; David-Neto E Int Urol Nephrol; 2014 Oct; 46(10):2053-4. PubMed ID: 25080208 [No Abstract] [Full Text] [Related] [Next] [New Search]